PF-04991532
Drug timelines are a Plus or Pro feature.
11 regulatory and trial events tracked for PF-04991532, covering 2010-08-05 to 2013-08-29. Get the full timeline:
Most recent: Clinical Trial Update: A 2-week Trial Of PF-04991532 In Patients With Type 2 Diabetes [Phase 1]